Soc. Generale Discount Zert CEC 2.../ DE000SV7LG39 /
| 2024-05-14 1:20:50 PM | Chg.+0.120 | Bid1:52:43 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 2.430EUR | +5.19% | 2.440 Bid Size: 9,000 |
- Ask Size: - |
CECONOMY AG INH O.N... | - EUR | 2024-06-28 | Call |
GlobeNewswire
1:55 PM
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
1:45 PM
Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended March 31, 2024 and t...
Newsfile Corp
1:44 PM
Appia Announces Encouraging Initial Results from the Newly Identified Taygeta and Merope Exploration...
GlobeNewswire
1:30 PM
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
1:30 PM
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
1:30 PM
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
1:30 PM
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
1:30 PM
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
1:30 PM
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
1:30 PM
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
1:30 PM
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire
1:30 PM
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
